alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Initial Review Group; Function, Integration, and Rehabilitation Sciences Study Section.                    

*Date:*                         October 22, 2021.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2137D, Bethesda, MD 20892 (Video-Assisted Meeting).                    

*Contact Person:*                         Helen Huang, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2137D, Bethesda, MD 20892, (301) 435-8207,                         *helen.huang@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: September 2, 2021.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-19354 Filed 9-3-21; 8:45 am]

BILLING CODE 4140-01-P
**Exhibit 10.49**

**Summary of Loan Agreement by and between Shenzhen BAK Battery Co., Ltd. and Shenzhen Eastern Branch, Agricultural Bank of China dated July 25, 2006.**

| **Summary of the main articles**    |
|-------------------------------------|
| •                              | Contract   number: No. 81101200600001251 |
| •                              | Loan   Principal: RMB 20 million; |
| •                              | Loan term: six   months starting from the date loan is actually provided to the Company. |
| •                              | Interest   rate: fixed rate of 5.40%; |
|                                | • | Penalty   interest rate for delayed repayment: 5.40% plus 50% *5.40%; |
|                                | • | Penalty   interest rate for embezzlement of loan proceeds: 5.40% * 2; |
| •                              | Purpose of   the loan is to provide working capital for the Company; |
| •                              | Advanced   repayment of loan needs to be approved by the Lender; |
| •                              | Breach of   contract penalties: suspension of loan not yet provided,   demand prepayment of loan principal and interest before maturity; imposition   of punitive interest; compensation for the Lender’s expenses incurred due to   the Company’s breach of contract such as lawyer’s fee, travel cost in case of   litigation, etc. |
| **Summary of the articles omitted** |
| •                              | Types of the   loan |
| •                              | Clearing of   the loan interest |
| •                              | Conditions   precedent to the drawing of the loan |
| •                              | Rights and   obligations of the Borrower |
| •                              | Rights and   obligations of the Lender |
| •                              | Guarantee of   the loan |
| •                              | Dispute   settlement |
| •                              | Miscellaneous |
| •                              | Validity |
| •                              | Notes |
Exhibit 32.2

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)

In connection with the Annual Report of China BAK Battery, Inc., a Nevada
corporation (the Company), on Form 10-K for the year ended September
30, 2006, as filed with the Securities and Exchange Commission (the
Report), Yongbin Han, Chief Financial Officer of the Company, does
hereby certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18
U.S.C. § 1350), that to his knowledge:

| | 1. | The Report   fully complies with the requirements of section 13(a) or 15(d) of the   Securities Exchange Act of 1934; and                              
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                        
| | 2. | The   information contained in the Report fairly presents, in all material   respects, the financial condition and result of operations of the Company.

|                 | /s/ Yongbin   Han        
|---------------- | -------------------------
|                 |                          
|                 | Yongbin Han              
|                 | Chief   Financial Officer
|December 8, 2006 |                          

---
Exhibit 31.1

                                  CERTIFICATION

I, Carroll Shelby, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Advanced Engine
Technologies, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
small business issuer as of, and for, the periods presented in this quarterly
report; and

4. The small business issuer's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

(b) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation;

(c) Disclosed in this quarterly report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter (the small business issuer's fourth
fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. The small business issuer's other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
the small business issuer's board of directors (or persons performing the
equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.


Date: February 17, 2004                   /s/  CARROLL SHELBY
                                        Carroll Shelby, President
exv4w1w3






Exhibit 4.1.3























 







     THE SECURITIES REPRESENTED BY THIS INSTRUMENT ARE NOT SAVINGS ACCOUNTS,
 DEPOSITS OR OTHER OBLIGATIONS OF A BANK AND ARE NOT INSURED BY THE FEDERAL DEPOSIT
INSURANCE CORPORATION OR ANY OTHER GOVERNMENTAL AGENCY.


     THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF
 ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A
REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE
 SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS.
 EACH PURCHASER OF THE SECURITIES REPRESENTED BY THIS INSTRUMENT IS NOTIFIED THAT THE SELLER
 MAY BE RELYING ON THE EXEMPTION FROM SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.
 ANY TRANSFEREE OF THE SECURITIES REPRESENTED BY THIS INSTRUMENT BY ITS ACCEPTANCE HEREOF (1) REPRESENTS
 THAT IT IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN RULE
 144A UNDER THE SECURITIES ACT), (2) AGREES THAT IT WILL NOT OFFER, SELL OR
 OTHERWISE TRANSFER THE SECURITIES REPRESENTED BY THIS INSTRUMENT EXCEPT (A)
PURSUANT TO A REGISTRATION STATEMENT WHICH IS THEN EFFECTIVE UNDER THE SECURITIES ACT,
 (B) FOR SO LONG AS THE SECURITIES REPRESENTED BY THIS INSTRUMENT ARE ELIGIBLE FOR RESALE
 PURSUANT TO RULE 144A, TO A PERSON IT REASONABLY BELIEVES IS A "QUALIFIED INSTITUTIONAL BUYER"
 AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE
 ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE
 IN RELIANCE ON RULE 144A, (C) TO THE ISSUER OR (D) PURSUANT TO ANY OTHER AVAILABLE EXEMPTION FROM THE
 REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND (3) AGREES THAT IT WILL GIVE TO EACH PERSON TO WHOM
 THE SECURITIES REPRESENTED BY THIS INSTRUMENT ARE TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND.
Skip to main content

Privacy Policy•Site map

# Rails to Trails Program Livestream | 2/23 at 9:30 a.m. 

Please mark your calendars for **Friday, February 23, at 9:30 a.m.** to livestream the Court’s upcoming outreach program on **Rails to Trails**litigation. The program is being hosted at the University of Florida Levin College of Law. Presenters include our very own Judge Armando O. Bonilla, Ms. Meghan Largent, Practice Group Leader of the Rails to Trails practice program of Lewis Rice, and Mr. Brian Herman, Senior Trial Attorney in the Department of Justice’s Environment and Natural Resources Division. Streaming will be available to court staff and the Court of Federal Claims Bar Association. 

You may register at this link, which can also be accessed by the QR code below. For any issues with streaming or receipt of the link, contact Ms. Ruth McIlhenny (rmcilhenny@ufl.edu). Also, please note that this program is available for 3.0 credits through the Florida Bar.

Howard T. Markey National Courts Building • 717 Madison Place, NW, Washington, DC 20439 • 202-357-6400
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Westell Technologies, Inc. (the Company) on Form 10-Q for the
fiscal period ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that based on their knowledge:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company as of and for the periods covered
in the Report.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                       
|-----------------------
|/s/ Richard S. Gilbert 
|Richard S. Gilbert     
|Chief Executive Officer
|August 7, 2009         
|                       
|/s/ Brian S. Cooper    
|Brian S. Cooper        
|Chief Financial Officer
|August 7, 2009         

A signed original of this written statement required by Section 906, or other document authenticating,
acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Westell Technologies, Inc. and will be retained by Westell
Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to
the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be considered filed as part of the Form 10-Q.



27
# C_2021455EN.01000101.xml

| 10.11.2021 | EN | Official Journal of the European Union | C 455/1 |
| --- | --- | --- | --- |

10.11.2021

EN

Official Journal of the European Union

C 455/1

---

Non-opposition to a notified concentration

(Case M.10018 – ifm electronic/Endress+ Hauser Group Services/Automation24/Process+Lab Devices Online)

(Text with EEA relevance)

(2021/C 455/01)

On 14 December 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in German language and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M10018. EUR-Lex is the online access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M10018. EUR-Lex is the online access to the European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
<PAGE>
                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Mpower Holding Corporation (the
"Company") on Form 10-K for the year ended December 31, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, S.
Gregory Clevenger, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of tHE Sarbanes-Oxley
Act of 2002, that to the best of my knowledge:

          (1) The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

          (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


/s/ S. Gregory Clevenger
------------------------------
S. Gregory Clevenger
Chief Financial Officer
March 28, 2003
---

---

# EXHIBIT 13.1

Certification
Pursuant to 18 U.S.C. Section 1350,as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

In
connection with the Annual Report on Form 20-F Tikcro Technologies Ltd. (the
Company) for the period ending December 31, 2004 as filed with the Securities
and Exchange Commission on or about the date hereof (the Report), I, Izhak
Tamir, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:

1.       
          the Report fully complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and

2.       
          the information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.

Date: June 27, 2005

|/S/ Izhak Tamir
Izhak TamirPrincipal Executive Officer andPrincipal Financial Officer
|---------------------------------------------------------------------------------------------------



---

---
Amendment to Employment Agreement between the Company and Joseph H. Crabb



 IMMUCELL CORPORATION 
 EXHIBIT 10.7 
 AMENDMENT TO EMPLOYMENT AGREEMENT 

 IMMUCELL CORPORATION, a Delaware corporation (the “Company”), and JOSEPH H. CRABB, an individual residing in
Falmouth, Maine (“Crabb”), hereby agree as follows as of this 26th day of March 2010. 
 1.        This agreement supersedes and replaces in its entirety the Employment Agreement, dated as of April 29, 1999, as amended by the Employment Agreement, dated January 1, 2005, and the
Employment Agreement, dated as of July 28, 2005, each between the Company and Crabb. This agreement, together with the Confidential Information, Inventions and Noncompete Agreement, dated of even date herewith, between the Company and Crabb and
any stock option agreements previously entered into between the Company and Crabb, constitute the parties’ entire understanding with respect to Crabb’s employment by the Company. 
 2.        Crabb shall serve as Vice President and Chief Scientific Officer of the Company in an
“at will” capacity on such terms as the Board of Directors of the Company may from time to time determine, subject to termination by the Board of Directors of the Company at any time, with or without cause. 
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement, intending the same to take effect as a sealed instrument, as of the
date first above written. 
  

			
	IMMUCELL CORPORATION
		
	By:	 	/s/ Linda Rhodes
		 	 Dr. Linda Rhodes

		 	 Chair of Compensation and

		 	 Stock Option Committee

		
	 /s/
	 	Joseph H. Crabb
	Joseph H. Crabb
Exhibit 31.1

                                  CERTIFICATION

I, Carroll Shelby, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Advanced Engine
Technologies, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
small business issuer as of, and for, the periods presented in this quarterly
report;

4. The small business issuer's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

(b) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation;

(c) Disclosed in this quarterly report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. The small business issuer's other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
the small business issuer's board of directors (or persons performing the
equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.

Date: February 14, 2005                            /s/CARROLL SHELBY
                                                   -----------------
                                                   Carroll Shelby, President